|
ERCC5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.20270000034817E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.007200E-04 |
| Normal-vs-Stage2 |
7.570300E-02 |
| Normal-vs-Stage3 |
1.021810E-01 |
| Normal-vs-Stage4 |
3.282800E-01 |
| Stage1-vs-Stage2 |
6.363400E-01 |
| Stage1-vs-Stage3 |
8.596200E-01 |
| Stage1-vs-Stage4 |
9.927600E-01 |
| Stage2-vs-Stage3 |
8.122600E-01 |
| Stage2-vs-Stage4 |
7.763800E-01 |
| Stage3-vs-Stage4 |
9.256200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6698299999951E-05 |
| Normal-vs-AfricanAmerican |
7.179300E-04 |
| Normal-vs-Asian |
3.421600E-01 |
| Caucasian-vs-AfricanAmerican |
4.246400E-01 |
| Caucasian-vs-Asian |
1.246830E-01 |
| AfricanAmerican-vs-Asian |
6.679800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.97109999999778E-06 |
| Normal-vs-Female |
1.216050E-03 |
| Male-vs-Female |
8.568000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.933700E-02 |
| Normal-vs-Extreme_Weight |
3.804700E-03 |
| Normal-vs-Obese |
2.038400E-04 |
| Normal-vs-Extreme_Obese |
2.323600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.961800E-01 |
| Normal_Weight-vs-Obese |
4.490400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.711800E-01 |
| Extreme_Weight-vs-Obese |
1.984220E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.648400E-01 |
| Obese-vs-Extreme_Obese |
5.102000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.503400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.81419999526022E-08 |
| Normal-vs-Age(61-80Yrs) |
2.683700E-03 |
| Normal-vs-Age(81-100Yrs) |
3.316200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.905610E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.767400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.262000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.496200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.801630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.212400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.94150000520921E-08 |
| Normal-VS-Type2 PRCC |
5.909800E-02 |
| Normal-VS-KIRP CIMP |
1.811620E-02 |
| Normal-VS-Unclassified PRCC |
5.575200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.354400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.56440000000213E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
7.200000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.695900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.811800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.152900E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.581800E-02 |
| Normal-vs-N1 |
1.846020E-02 |
| Normal-vs-N2 |
1.031350E-01 |
| N0-vs-N1 |
8.988300E-02 |
| N0-vs-N2 |
1.027830E-01 |
| N1-vs-N2 |
3.485000E-03 |
|
|
